Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 214,310 | -411 | -5,607 | -2,510 | -5,347 |
| Depreciation Amortization | 3,819 | 2,213 | 2,460 | 2,098 | 1,233 |
| Income taxes - deferred | -1,775 | -21 | 36 | -336 | 246 |
| Accounts receivable | -178,480 | -839 | -1,970 | 214 | -2,322 |
| Accounts payable and accrued liabilities | 22,617 | -329 | 102 | -363 | 1,094 |
| Other Working Capital | -91,451 | -915 | -1,244 | -714 | -1,857 |
| Other Operating Activity | 171,588 | 5,819 | 5,548 | 2,942 | 11,358 |
| Operating Cash Flow | $140,628 | $5,517 | $-675 | $1,331 | $4,405 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -304,440 | -27,727 | 3,782 | -474 | -39,017 |
| PPE Investments | -35,122 | -1,182 | -2,832 | -5,356 | -3,778 |
| Purchase Of Investment | -3,971 | -137 | N/A | N/A | N/A |
| Sale Of Investment | 17,095 | 0 | N/A | 3,781 | N/A |
| Investing Cash Flow | $-326,438 | $-29,046 | $950 | $-2,049 | $-42,795 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15,019 | 0 | N/A | N/A | N/A |
| Common Stock Issued | 246,294 | 28,796 | 15 | 31 | 36,790 |
| Common Stock Repurchased | -62 | -21 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -801 | 8,999 |
| Financing Cash Flow | $261,251 | $28,775 | $15 | $-770 | $45,789 |
| Exchange Rate Effect | 20 | -17 | -44 | 81 | N/A |
| Beginning Cash Position | 11,965 | 6,736 | 6,490 | 7,897 | 498 |
| End Cash Position | 87,426 | 11,965 | 6,736 | 6,490 | 7,897 |
| Net Cash Flow | $75,461 | $5,229 | $246 | $-1,407 | $7,399 |
| Free Cash Flow | |||||
| Operating Cash Flow | 140,628 | 5,517 | -675 | 1,331 | 4,405 |
| Capital Expenditure | -35,130 | -1,182 | -2,832 | -5,356 | -3,788 |
| Free Cash Flow | 105,498 | 4,335 | -3,507 | -4,025 | 617 |